title: Limited clinical usefulness of plasma corticotropin-releasing hormone, adrenocorticotropin and beta-endorphin measurements as markers of lung cancer.
abstract: We measured plasma corticotropin-releasing hormone (CRH), ACTH, beta-endorphin (beta-EP), and cortisol levels as possible tumor markers in a sequence of 103, randomly selected, patients with lung cancer but without the ectopic Cushing's syndrome and in 72 age- and sex-matched controls. Plasma CRH levels of cancer patients were similar to those of controls both in patients sampled in the morning or in the afternoon. On the other hand, plasma ACTH levels of cancer patients were significantly higher than control patients both in the morning and in the afternoon and showed a preserved circadian rhythm. However, about 35% of cancer patients sampled in the morning and about 60% of those sampled in the afternoon had ACTH levels within the 95% confidence interval (CI) of controls. Also plasma beta-EP levels were more elevated in cancer patients than controls in the morning but about 33% of them and about 80% of those sampled in the afternoon had beta-EP levels within the 95% CI of controls. Despite the higher plasma ACTH levels, cancer patients had cortisol plasma levels similar to controls with preserved circadian rhythm. In conclusion, although mean plasma ACTH and beta-EP were higher in patients affected by lung cancer, their measurements, as well as those of CRH, have practically no diagnostic value. Perhaps measurement of ACTH levels in the bronchial lavage may be more helpful.
authors.affiliation: Istituto di Clinica Medica I, Università di Catania, Italy.
authors.forename: A E
authors.initials: AE
authors.lastname: Calogero
authors.forename: G
authors.initials: G
authors.lastname: Minacapilli
authors.forename: A M
authors.initials: AM
authors.lastname: Nicolosi
authors.forename: M L
authors.initials: ML
authors.lastname: Moncada
authors.forename: A
authors.initials: A
authors.lastname: Mistretta
authors.forename: S F
authors.initials: SF
authors.lastname: Latteri
authors.forename: P
authors.initials: P
authors.lastname: Polosa
authors.forename: R
authors.initials: R
authors.lastname: D'Agata
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D002940:Circadian Rhythm; D003346:Corticotropin-Releasing Hormone / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D008175:Lung Neoplasms / Q000097:blood*; D008875:Middle Aged; D001615:beta-Endorphin / Q000097:blood*
chemical_list: D014408:Biomarkers, Tumor; D001615:beta-Endorphin; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D006854:Hydrocortisone